NR3C2 and Hypertension: The aim of this study was therefore, to investigate changes in cardiac and kidney functional parameters and associated cardiac and kidney interstitial fibrosis, following an induced myocardial infarction in animals with established progressive hypertension, and how the resultant pathophysiology may be modified by treatment with the mineralocorticoid receptor antagonist spironolactone.